Neuregulin 1 and susceptibility to schizophrenia.
paper
Cited
Public
Unavailable
- Authors
- Stefansson, Hreinn; Sigurdsson, Engilbert; Steinthorsdottir, Valgerdur; Bjornsdottir, Soley; Sigmundsson, Thordur; Ghosh, Shyamali; Brynjolfsson, Jon; Gunnarsdottir, Steinunn; Ivarsson, Omar; Chou, Thomas T; Hjaltason, Omar; Birgisdottir, Birgitta; Jonsson, Helgi; Gudnadottir, Vala G; Gudmundsdottir, Elsa; Bjornsson, Asgeir; Ingvarsson, Brynjolfur; Ingason, Andres; Sigfusson, Sigmundur; Hardardottir, Hronn; Harvey, Richard P; Lai, Donna; Zhou, Mingdong; Brunner, Daniela; Mutel, Vincent; Gonzalo, Acuna; Lemke, Greg; Sainz, Jesus; Johannesson, Gardar; Andresson, Thorkell; Gudbjartsson, Daniel; Manolescu, Andrei; Frigge, Michael L; Gurney, Mark E; Kong, Augustine; Gulcher, Jeffrey R; Petursson, Hannes; Stefansson, Kari
- Year
- 2002
- Journal
- American journal of human genetics
- PMID
- 12145742
- DOI
- 10.1086/342734
- PMCID
- PMC378543
The cause of schizophrenia is unknown, but it has a significant genetic component. Pharmacologic studies, studies of gene expression in man, and studies of mouse mutants suggest involvement of glutamate and dopamine neurotransmitter systems. However, so far, strong association has not been found between schizophrenia and variants of the genes encoding components of these systems. Here, we report the results of a genomewide scan of schizophrenia families in Iceland; these results support previous work, done in five populations, showing that schizophrenia maps to chromosome 8p. Extensive fine-mapping of the 8p locus and haplotype-association analysis, supplemented by a transmission/disequilibrium test, identifies neuregulin 1 (NRG1) as a candidate gene for schizophrenia. NRG1 is expressed at central nervous system synapses and has a clear role in the expression and activation of neurotransmitter receptors, including glutamate receptors. Mutant mice heterozygous for either NRG1 or its receptor, ErbB4, show a behavioral phenotype that overlaps with mouse models for schizophrenia. Furthermore, NRG1 hypomorphs have fewer functional NMDA receptors than wild-type mice. We also demonstrate that the behavioral phenotypes of the NRG1 hypomorphs are partially reversible with clozapine, an atypical antipsychotic drug used to treat schizophrenia.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Depth-specific changes in cortical T1w/T2w ratio are associated with impaired executive function in chronic schizophrenia. | Schur GM et al. | β | 2026 | β |
| Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3Ξ² signaling pathway, galectin-3 and MBP. | Salama A et al. | β | 2026 | β |
| Cannabis Use and Glutamate across the Psychosis Spectrum: In Vivo Evidence from 7T Proton Magnetic Resonance Spectroscopy | Roalf D et al. | β | 2025 | β |
| Common Genomic and Proteomic Alterations Related to Disturbed Neural Oscillatory Activity in Schizophrenia. | Trombka D et al. | β | 2025 | β |
| ErbB inhibition rescues nigral dopamine neuron hyperactivity and repetitive behaviors in a mouse model of fragile X syndrome. | D'Addario SL et al. | β | 2025 | β |
| Long non-coding RNAs in schizophrenia. | Mousavinejad SN et al. | β | 2025 | β |
| Multiple Roles for Neuregulins and Their v-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog Receptors in Neurodegenerative Disease Pathogenesis and Therapy. | Turner-Ivey B et al. | β | 2025 | β |
| Postnatal critical-period brain plasticity and neurodevelopmental disorders: revisited circuit mechanisms. | Shang Z et al. | β | 2025 | β |
| Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta-analysis. | Carnaval T et al. | β | 2025 | β |
| Synergistic SNP-SNP interaction of NRG1 and ERBB4 increases the risk of schizophrenia. | Norovsambuu O et al. | β | 2025 | β |
| Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways. | Zhang T et al. | β | 2024 | β |
| Delineating mechanisms underlying parvalbumin neuron impairment in different neurological and neurodegenerative disorders: the emerging role of mitochondrial dysfunction. | Olkhova EA et al. | β | 2024 | β |
| Discovering functional interactions among schizophrenia-risk genes by combining behavioral genetics with cell biology. | Ma D et al. | β | 2024 | β |
| Dysregulation of myelination-related genes in schizophrenia. | Bergstrom JJD et al. | β | 2024 | β |
| Gene expression changes in Brodmann's Area 46 differentiate epidermal growth factor and immune system interactions in schizophrenia and mood disorders. | Ketharanathan T et al. | β | 2024 | β |
| Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer. | Adashek JJ et al. | β | 2024 | β |
| NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia. | Dwyer GE et al. | β | 2024 | β |
| Nrg1 intracellular signaling regulates the development of interhemispheric callosal axons in mice. | RodrΓguez-Prieto Γ et al. | β | 2024 | β |
| Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches toΒ insights of susceptibility genes. | Lv Y et al. | β | 2024 | β |
| The Role of NOTCH Pathway Genes in the Inherited Susceptibility to Aortic Stenosis. | Irtyuga O et al. | β | 2024 | β |
| A Missense Variant in CASKIN1's Proline-Rich Region Segregates with Psychosis in a Three-Generation Family. | Wahbeh MH et al. | β | 2023 | β |
| BACE1-dependent metabolism of neuregulin 1: Bridging the gap in explaining the occurrence of schizophrenia-like symptoms in Alzheimer's disease with psychosis? | Vincent B et al. | β | 2023 | β |
| Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model. | Hampel H et al. | β | 2023 | β |
| Distinctive effects of NMDA receptor modulators on cerebral microcirculation in a schizophrenia mouse model. | Ju J et al. | β | 2023 | β |
| Genetic Influences on Cognitive Dysfunction in Schizophrenia. | Greenwood TA | β | 2023 | β |
| Genetic labeling reveals spatial and cellular expression pattern of neuregulin 1 in mouse brain. | Ding CY et al. | β | 2023 | β |
| GluN2D Subunit in Parvalbumin Interneurons Regulates Prefrontal Cortex Feedforward Inhibitory Circuit and Molecular Networks Relevant to Schizophrenia. | Gawande DY et al. | β | 2023 | β |
| LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features. | Villalonga E et al. | β | 2023 | β |
| Neuregulin-1/PI3K signaling effects on oligodendrocyte proliferation, remyelination and behaviors deficit in a male mouse model of ischemic stroke. | Cui MY et al. | β | 2023 | β |
| Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors. | Khan MM et al. | β | 2023 | β |
| Rats, Neuregulins and Radical Prostatectomy: A Conceptual Overview. | Novacescu D et al. | β | 2023 | β |
| Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System. | Sotoyama H et al. | β | 2023 | β |
| The genetic basis of onset age in schizophrenia: evidence and models. | Zhan N et al. | β | 2023 | β |
| The genetics of autism spectrum disorder in an East African familial cohort. | Tuncay IO et al. | β | 2023 | β |
| The laterodorsal tegmentum-ventral tegmental area circuit controls depression-like behaviors by activating ErbB4 in DA neurons. | Wang H et al. | β | 2023 | β |
| The molecular genetic basis of creativity: a mini review and perspectives. | Zhang S et al. | β | 2023 | β |
| Adult neural stem cells and schizophrenia. | Hu L et al. | β | 2022 | β |
| Advantages and Limitations of Animal Schizophrenia Models. | BiaΕoΕ M et al. | β | 2022 | β |
| Alterations in prefrontal cortical neuregulin-1 levels in post-pubertal rats with neonatal ventral hippocampal lesions. | Watanabe K et al. | β | 2022 | β |
| An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data. | Zhang CY et al. | β | 2022 | β |
| A Novel Gene Controls a New Structure: PiggyBac Transposable Element-Derived 1, Unique to Mammals, Controls Mammal-Specific Neuronal Paraspeckles. | RaskΓ³ T et al. | β | 2022 | β |
| Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes. | Prats C et al. | β | 2022 | β |
| Developmental, neurochemical, and behavioral analyses of ErbB4 Cyt-1 knockout mice. | Erben L et al. | β | 2022 | β |
| Effects of psychosis-associated genetic markers on brain volumetry: a systematic review of replicated findings and an independent validation. | Vouga Ribeiro N et al. | β | 2022 | β |
| Epistatic interactions of NRG1 and ERBB4 on antipsychotic treatment response in first-episode schizophrenia patients. | Zhang Y et al. | β | 2022 | β |
| ErbB4 in the brain: Focus on high grade glioma. | Pitcher JL et al. | β | 2022 | β |
| FAM69C, a kinase critical for synaptic function and memory, is defective in neurodegenerative dementia. | Mei F et al. | β | 2022 | β |
| Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder. | Nakamura S | β | 2022 | β |
| Investigating the Role of GABA in Neural Development and Disease Using Mice Lacking GAD67 or VGAT Genes. | Bolneo E et al. | β | 2022 | β |
| Investigation of <i>OLIG2</i> as a candidate gene for schizophrenia and autism spectrum disorder. | Furuta S et al. | β | 2022 | β |
| Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents-in celebration of 80th birthday of Professor Peter Riederer. | Tanaka M et al. | β | 2022 | β |
| New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3, CSMD1 and NRG1 genes. | Mestiri S et al. | β | 2022 | β |
| Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study. | Vrillon A et al. | β | 2022 | β |
| Plasticity-Related Gene 5 Is Expressed in a Late Phase of Neurodifferentiation After Neuronal Cell-Fate Determination. | Gross I et al. | β | 2022 | β |
| Repeated Winning and Losing Experiences in Chronic Social Conflicts Are Linked to RNA Editing Pattern Difference. | Ru FX et al. | β | 2022 | β |
| Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats. | Nawwar DA et al. | β | 2022 | β |
| SELENBP1 overexpression in the prefrontal cortex underlies negative symptoms of schizophrenia. | Kim S et al. | β | 2022 | β |
| The effects of preventative cannabidiol in a male <i>neuregulin 1</i> mouse model of schizophrenia. | Visini G et al. | β | 2022 | β |
| The Long Non-Coding RNA <i>GOMAFU</i> in Schizophrenia: Function, Disease Risk, and Beyond. | Zakutansky PM et al. | β | 2022 | β |
| Toxic and Phenotypic Effects of AAV_Cre Used to Transduce Mesencephalic Dopaminergic Neurons. | Erben L et al. | β | 2022 | β |
| What Can We Learn from Animal Models to Study Schizophrenia? | Crunfli F et al. | β | 2022 | β |
| White matter alterations and the conversion to psychosis: A combined diffusion tensor imaging and glutamate <sup>1</sup>H MRS study. | LeΓ³n-Ortiz P et al. | β | 2022 | β |
| Autism and severe clinical phenotype in a patient with 8p21.2p11.21 deletion: Case report and literature review. | Arghir A et al. | β | 2021 | β |
| Brain changes in NF-ΞΊB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation. | Ketharanathan T et al. | β | 2021 | β |
| Brain Network Simulations Indicate Effects of Neuregulin-1 Genotype on Excitation-Inhibition Balance in Cortical Dynamics. | Klein PC et al. | β | 2021 | β |
| Cre-Activation in ErbB4-Positive Neurons of Floxed <i>Grin1</i>/NMDA Receptor Mice Is Not Associated With Major Behavioral Impairment. | Mallien AS et al. | β | 2021 | β |
| Differential methylation of imprinting genes and MHC locus in 22q11.2 deletion syndrome-related schizophrenia spectrum disorders. | Carmel M et al. | β | 2021 | β |
| Disorganization of Oscillatory Activity in Animal Models of Schizophrenia. | Speers LJ et al. | β | 2021 | β |
| Dopamine System, NMDA Receptor and EGF Family Expressions in Brain Structures of Bl6 and 129Sv Strains Displaying Different Behavioral Adaptation. | Varul J et al. | β | 2021 | β |
| Early Detection and Prevention of Schizophrenic Psychosis-A Review. | Westhoff MLS et al. | β | 2021 | β |
| Global Scientific Outputs of Schizophrenia Publications From 1975 to 2020: a Bibliometric Analysis. | Kiraz S et al. | β | 2021 | β |
| Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks. | GΓΆtze T et al. | β | 2021 | β |
| Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features. | SΓ‘nchez-GonzΓ‘lez A et al. | β | 2021 | β |
| Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research. | Grubisha MJ et al. | β | 2021 | β |
| Neuregulins in Neurodegenerative Diseases. | Ou GY et al. | β | 2021 | β |
| Neurobiological substrates of major psychiatry disorders: transdiagnostic associations between white matter abnormalities, neuregulin 1 and clinical manifestation. | Duan J et al. | β | 2021 | β |
| Nrg1 haploinsufficiency alters inhibitory cortical circuits. | Navarro-Gonzalez C et al. | β | 2021 | β |
| Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition. | Wang YY et al. | β | 2021 | β |
| Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia. | Yang J et al. | β | 2021 | β |
| Plasticity in oligodendrocyte lineage progression: An OPC puzzle on our nerves. | Craig GA et al. | β | 2021 | β |
| Rare Pathogenic Variants in Genes Implicated in Glutamatergic Neurotransmission Pathway Segregate with Schizophrenia in Pakistani Families. | Fatima A et al. | β | 2021 | β |
| Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in <i>neuregulin 1 type III</i> overexpressing mice. | Chesworth R et al. | β | 2021 | β |
| Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation. | Chen P et al. | β | 2021 | β |
| Striatal transcriptome changes linked to drug-induced repetitive behaviors. | Crittenden JR et al. | β | 2021 | β |
| The dual hit hypothesis of schizophrenia: Evidence from animal models. | Guerrin CGJ et al. | β | 2021 | β |
| The importance of non-coding RNAs in environmental stress-related developmental brain disorders: A systematic review of evidence associated with exposure to alcohol, anesthetic drugs, nicotine, and viral infections. | Arzua T et al. | β | 2021 | β |
| Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models. | Dunn AL et al. | β | 2020 | β |
| A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk. | Sydnor VJ et al. | β | 2020 | β |
| Beneficial Effects of Fingolimod on Social Interaction, CNS and Peripheral Immune Response in the BTBR Mouse Model of Autism. | De Simone R et al. | β | 2020 | β |
| CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease. | Mouton-Liger F et al. | β | 2020 | β |
| Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia. | Donegan JJ et al. | β | 2020 | β |
| GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-NaΓ―ve Patients with Schizophrenia. | Zhang C et al. | β | 2020 | β |
| Insights on the Functional Interaction between Group 1 Metabotropic Glutamate Receptors (mGluRI) and ErbB Receptors. | Ledonne A et al. | β | 2020 | β |
| Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders. | Shi L et al. | β | 2020 | β |
| Neuregulins 1, 2, and 3 Promote Early Neurite Outgrowth in ErbB4-Expressing Cortical GABAergic Interneurons. | Rahman-Enyart A et al. | β | 2020 | β |
| Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders. | Dhuriya YK et al. | β | 2020 | β |
| Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia. | GouvΓͺa-Junqueira D et al. | β | 2020 | β |
| Parvalbumin Interneuron Activation-Dependent Adult Hippocampal Neurogenesis Is Required for Treadmill Running to Reverse Schizophrenia-Like Phenotypes. | Yi Y et al. | β | 2020 | β |
| Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development. | Schoonover KE et al. | β | 2020 | β |
| Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. | Zamanpoor M | β | 2020 | β |
| Sex-specific and shared expression profiles of vulnerability and resilience to trauma in brain and blood. | Kim GS et al. | β | 2020 | β |
| Solute Carrier Family 1 (<i>SLC1A1</i>) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population. | Li W et al. | β | 2020 | β |
| Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia. | Peitl V et al. | β | 2020 | β |
| A critical review of zebrafish schizophrenia models: Time for validation? | Gawel K et al. | β | 2019 | β |
| Acute stress-induced change in polysialic acid levels mediated by sialidase in mouse brain. | Abe C et al. | β | 2019 | β |
| An Overview of Animal Models Related to Schizophrenia. | Winship IR et al. | β | 2019 | β |
| Developing zebrafish experimental animal models relevant to schizophrenia. | Demin KA et al. | β | 2019 | β |
| Effect of age onset on schizophrenia-like phenotypes and underlying mechanisms in model mice. | Ju J et al. | β | 2019 | β |
| Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment. | Huang XF et al. | β | 2019 | β |
| Elevated cleavage of neuregulin-1 by beta-secretase 1 in plasma of schizophrenia patients. | Zhang Z et al. | β | 2019 | β |
| erbb4 Deficits in Chandelier Cells of the Medial Prefrontal Cortex Confer Cognitive Dysfunctions: Implications for Schizophrenia. | Yang JM et al. | β | 2019 | β |
| Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia. | Zai CC et al. | β | 2019 | β |
| Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. | Greenwood TA et al. | β | 2019 | β |
| Neuregulin1Ξ² improves both spatial and associative learning and memory in Alzheimer model of rats possibly through signaling pathways other than Erk1/2. | Jalilzad M et al. | β | 2019 | β |
| Neuroprotection by Exogenous and Endogenous Neuregulin-1 in Mouse Models of Focal Ischemic Stroke. | Noll JM et al. | β | 2019 | β |
| NMDAR Hypofunction Animal Models of Schizophrenia. | Lee G et al. | β | 2019 | β |
| On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity. | Ledonne A et al. | β | 2019 | β |
| Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia. | Ni P et al. | β | 2019 | β |
| Sex differences in gene expression related to antipsychotic induced weight gain. | Sainz J et al. | β | 2019 | β |
| The Association Between Schizophrenia Risk Variants and Creativity in Healthy Han Chinese Subjects. | Wang D et al. | β | 2019 | β |
| The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model. | Yao L et al. | β | 2019 | β |
| Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke. | Ryu S et al. | β | 2019 | β |
| A Genetic Study of Psychosis in Huntington's Disease: Evidence for the Involvement of Glutamate Signaling Pathways. | Tsuang DW et al. | β | 2018 | β |
| A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution. | Erben L et al. | β | 2018 | β |
| Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice. | Dominguez SL et al. | β | 2018 | β |
| Assessment of genotyping tools applied in genetic susceptibility studies of periodontal disease: A systematic review. | de Coo A et al. | β | 2018 | β |
| A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia. | Jagannath V et al. | β | 2018 | β |
| Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. | Mohammadi A et al. | β | 2018 | β |
| Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice. | Marchisella E et al. | β | 2018 | β |
| Defects in Bioenergetic Coupling in Schizophrenia. | Sullivan CR et al. | β | 2018 | β |
| Electrical Stimulation with a Conductive Polymer Promotes Neurite Outgrowth and Synaptogenesis in Primary Cortical Neurons in 3D. | Zhang Q et al. | β | 2018 | β |
| Exome Sequencing Identifies <i>TENM4</i> as a Novel Candidate Gene for Schizophrenia in the SCZD2 Locus at 11q14-21. | Xue CB et al. | β | 2018 | β |
| Genetic Background of Hirschsprung Disease: A Bridge Between Basic Science and Clinical Application. | Bahrami A et al. | β | 2018 | β |
| Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice. | Wang H et al. | β | 2018 | β |
| Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats. | Wang W et al. | β | 2018 | β |
| Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia. | Marballi KK et al. | β | 2018 | β |
| Inhibition of STEP<sub>61</sub> ameliorates deficits in mouse and hiPSC-based schizophrenia models. | Xu J et al. | β | 2018 | β |
| Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders. | Selten M et al. | β | 2018 | β |
| Levels of peripheral Neuregulin 1 are increased in non-medicated autism spectrum disorder patients. | Esnafoglu E | β | 2018 | β |
| Mental disorders and an acidic glycan-from the perspective of polysialic acid (PSA/polySia) and the synthesizing enzyme, ST8SIA2. | Sato C et al. | β | 2018 | β |
| mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling. | Ledonne A et al. | β | 2018 | β |
| Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory. | Ledonne A et al. | β | 2018 | β |
| Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK. | Kotzadimitriou D et al. | β | 2018 | β |
| Neuregulin1 types mRNA level changes in autism spectrum disorder, and is associated with deficit in executive functions. | Abbasy S et al. | β | 2018 | β |
| Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders. | Yan L et al. | β | 2018 | β |
| Neuregulin 3 and its roles in schizophrenia risk and presentation. | Avramopoulos D | β | 2018 | β |
| Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons. | MΓΌller T et al. | β | 2018 | β |
| Overexpression of Neuregulin 1 Type III Confers Hippocampal mRNA Alterations and Schizophrenia-Like Behaviors in Mice. | Olaya JC et al. | β | 2018 | β |
| Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia. | Marissal T et al. | β | 2018 | β |
| Sex Differences in Psychiatric Disease: A Focus on the Glutamate System. | Wickens MM et al. | β | 2018 | β |
| The Endocannabinoid System across Postnatal Development in Transmembrane Domain <i>Neuregulin 1</i> Mutant Mice. | Chesworth R et al. | β | 2018 | β |
| Trophic modulation of gamma oscillations: The key role of processing protease for Neuregulin-1 and BDNF precursors. | Tamura H et al. | β | 2018 | β |
| A brief history of the study of nerve dependent regeneration. | Farkas JE et al. | β | 2017 | β |
| A functional neuregulin-1 gene variant and stressful life events: Effect on drug use in a longitudinal population-representative cohort study. | Vaht M et al. | β | 2017 | β |
| A Gene-Based Analysis of Acoustic Startle Latency. | Smith AK et al. | β | 2017 | β |
| A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen. | Chen X et al. | β | 2017 | β |
| Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia: A meta-analysis of case-control studies. | Feng Y et al. | β | 2017 | β |
| Association of Established Thyroid-stimulating Hormone and Free Thyroxine Genetic Variants with Hashimoto's Thyroiditis. | BrΔiΔ L et al. | β | 2017 | β |
| Axonal Type III Nrg1 Controls Glutamate Synapse Formation and GluA2 Trafficking in Hippocampal-Accumbens Connections. | Zhong C et al. | β | 2017 | β |
| BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia. | Zhang Z et al. | β | 2017 | β |
| Cannabinoids as hippocampal network administrators. | Lupica CR et al. | β | 2017 | β |
| Chlorpromazine Increases the Expression of Polysialic Acid (PolySia) in Human Neuroblastoma Cells and Mouse Prefrontal Cortex. | Abe C et al. | β | 2017 | β |
| Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. | Alural B et al. | β | 2017 | β |
| Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis. | Ham S et al. | β | 2017 | β |
| Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease. | Yang D et al. | β | 2017 | β |
| Electrical Stimulation Using Conductive Polymer Polypyrrole Counters Reduced Neurite Outgrowth of Primary Prefrontal Cortical Neurons from NRG1-KO and DISC1-LI Mice. | Zhang Q et al. | β | 2017 | β |
| Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders. | Torres VI et al. | β | 2017 | β |
| Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia. | Clarke DJ et al. | β | 2017 | β |
| Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 Γ DISC1. | O'Tuathaigh CM et al. | β | 2017 | β |
| ErbB4 protects against neuronal apoptosis via activation of YAP/PIK3CB signaling pathway in a rat model of subarachnoid hemorrhage. | Yan F et al. | β | 2017 | β |
| Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples. | Mandage R et al. | β | 2017 | β |
| Genetics of psychosis of Alzheimer disease. | Shah C et al. | β | 2017 | β |
| Genome-wide association study of working memory brain activation. | Blokland GAM et al. | β | 2017 | β |
| Glutamate-dependent ectodomain shedding of neuregulin-1 type II precursors in rat forebrain neurons. | Iwakura Y et al. | β | 2017 | β |
| Hippocampal GABAergic Inhibitory Interneurons. | Pelkey KA et al. | β | 2017 | β |
| Meta-analysis reveals associations between genetic variation in the 5' and 3' regions of Neuregulin-1 and schizophrenia. | Mostaid MS et al. | β | 2017 | β |
| Microglia-derived neuregulin expression in psychiatric disorders. | Ikawa D et al. | β | 2017 | β |
| Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model. | Schneider S et al. | β | 2017 | β |
| Parent-of-origin effects on schizophrenia-relevant behaviours of type III neuregulin 1 mutant mice. | Shang K et al. | β | 2017 | β |
| Physiological Functions of the Ξ²-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2. | Yan R | β | 2017 | β |
| Role of BACE1 in Alzheimer's synaptic function. | Das B et al. | β | 2017 | β |
| Schizophrenia and neurogenesis: A stem cell approach. | Iannitelli A et al. | β | 2017 | β |
| Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1. | O'Tuathaigh CMP et al. | β | 2017 | β |
| Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice. | Wehr MC et al. | β | 2017 | β |
| The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies. | Harari JH et al. | β | 2017 | β |
| Understanding principles of integration and segregation using whole-brain computational connectomics: implications for neuropsychiatric disorders. | Lord LD et al. | β | 2017 | β |
| Variation at NRG1 genotype related to modulation of small-world properties of the functional cortical network. | Lubeiro A et al. | β | 2017 | β |
| Alzheimer's therapy targeting the Ξ²-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies. | Ohno M | β | 2016 | β |
| Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. | Ayhan Y et al. | β | 2016 | β |
| A reverse genetic approach identifies an ancestral frameshift mutation in RP1 causing recessive progressive retinal degeneration in European cattle breeds. | Michot P et al. | β | 2016 | β |
| Association of the DISC1 and NRG1 genetic polymorphisms with schizophrenia in a Chinese population. | He BS et al. | β | 2016 | β |
| Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model. | Papaleo F et al. | β | 2016 | β |
| Behavioural effects of high fat diet in a mutant mouse model for the schizophrenia risk gene neuregulin 1. | Holm-Hansen S et al. | β | 2016 | β |
| Brain-specific Crmp2 deletion leads to neuronal development deficits and behavioural impairments in mice. | Zhang H et al. | β | 2016 | β |
| Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence. | Rohleder C et al. | β | 2016 | β |
| Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations. | Dean B et al. | β | 2016 | β |
| Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function. | Braun U et al. | β | 2016 | β |
| Effects of neuregulin-1 administration on neurogenesis in the adult mouse hippocampus, and characterization of immature neurons along the septotemporal axis. | Mahar I et al. | β | 2016 | β |
| Effects of NRG1 genotypes on orbitofrontal sulcogyral patterns in Japanese patients diagnosed with schizophrenia. | Yoshimi A et al. | β | 2016 | β |
| From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. | Cariaga-Martinez A et al. | β | 2016 | β |
| Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System. | Munro KM et al. | β | 2016 | β |
| Gene Γ Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models. | Moran P et al. | β | 2016 | β |
| Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. | Greenwood TA et al. | β | 2016 | β |
| Genetic association between NRG1 and schizophrenia, major depressive disorder, bipolar disorder in Han Chinese population. | Wen Z et al. | β | 2016 | β |
| Genetics of Substance Use Disorders. | Yu C et al. | β | 2016 | β |
| Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. | Sherva R et al. | β | 2016 | β |
| Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior. | Dries DR et al. | β | 2016 | β |
| Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. | Edwards AC et al. | β | 2016 | β |
| mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia. | Engel M et al. | β | 2016 | β |
| Molecular substrates of schizophrenia: homeostatic signaling to connectivity. | Landek-Salgado MA et al. | β | 2016 | β |
| Mouse Genetic Models of Human Brain Disorders. | Leung C et al. | β | 2016 | β |
| Mutation of the 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Substrate-Docking Site in the Developing Brain Causes Microcephaly with Abnormal Brain Morphogenesis Independently of Akt, Leading to Impaired Cognition and Disruptive Behaviors. | CordΓ³n-Barris L et al. | β | 2016 | β |
| Neural circuit dysfunction in schizophrenia: Insights from animal models. | Sigurdsson T | β | 2016 | β |
| Neuregulin-1 and schizophrenia in the genome-wide association study era. | Mostaid MS et al. | β | 2016 | β |
| Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's disease. | Jiang Q et al. | β | 2016 | β |
| Neuregulin 1 Promotes Glutathione-Dependent Neuronal Cobalamin Metabolism by Stimulating Cysteine Uptake. | Zhang Y et al. | β | 2016 | β |
| Neuregulin-1 Regulates Cortical Inhibitory Neuron Dendrite and Synapse Growth through DISC1. | Unda BK et al. | β | 2016 | β |
| Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders. | Hayes LN et al. | β | 2016 | β |
| Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling. | Hu X et al. | β | 2016 | β |
| Primary phospholipase C and brain disorders. | Yang YR et al. | β | 2016 | β |
| Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies. | Carvajal FJ et al. | β | 2016 | β |
| Striatal but not frontal cortical up-regulation of the epidermal growth factor receptor in rats exposed to immune activation in utero and cannabinoid treatment in adolescence. | Idrizi R et al. | β | 2016 | β |
| Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model. | Li C et al. | β | 2016 | β |
| The importance of the excitatory amino acid transporter 3 (EAAT3). | BjΓΈrn-Yoshimoto WE et al. | β | 2016 | β |
| Use of conducting polymers to facilitate neurite branching in schizophrenia-related neuronal development. | Stewart EM et al. | β | 2016 | β |
| A joint history of the nature of genetic variation and the nature of schizophrenia. | Kendler KS | β | 2015 | β |
| Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk. | Huentelman MJ et al. | β | 2015 | β |
| Calcyon stimulates neuregulin 1 maturation and signaling. | Yin DM et al. | β | 2015 | β |
| Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. | Gao R et al. | β | 2015 | β |
| Common variants in the MKL1 gene confer risk of schizophrenia. | Luo XJ et al. | β | 2015 | β |
| Decreased plasma levels of neureglin-1 in drug naΓ―ve patients and chronic patients with schizophrenia. | Wang R et al. | β | 2015 | β |
| Development of cortical interneurons. | Chu J et al. | β | 2015 | β |
| Diffusion tensor imaging in first degree relatives of schizophrenia and bipolar disorder patients. | Arat HE et al. | β | 2015 | β |
| ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia. | Perez-Garcia CG | β | 2015 | β |
| ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children. | Douet V et al. | β | 2015 | β |
| Evaluating historical candidate genes for schizophrenia. | Farrell MS et al. | β | 2015 | β |
| Evidence for schizophrenia susceptibility alleles in the Indian population: An association of neurodevelopmental genes in case-control and familial samples. | Jajodia A et al. | β | 2015 | β |
| Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia. | Ingason A et al. | β | 2015 | β |
| Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility. | Andrews JL et al. | β | 2015 | β |
| Glia-related genes and their contribution to schizophrenia. | Wang C et al. | β | 2015 | β |
| Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia. | Joseph J et al. | β | 2015 | β |
| Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex. | Seshadri S et al. | β | 2015 | β |
| Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone. | Higa-Nakamine S et al. | β | 2015 | β |
| Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia. | Wang D et al. | β | 2015 | β |
| Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation. | Hemmerle AM et al. | β | 2015 | β |
| Myelin, myelin-related disorders, and psychosis. | Mighdoll MI et al. | β | 2015 | β |
| Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1). | Yu HN et al. | β | 2015 | β |
| Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse. | Long LE et al. | β | 2015 | β |
| Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice. | Engel M et al. | β | 2015 | β |
| Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. | Ledonne A et al. | β | 2015 | β |
| Neuregulin 1 Type II-ErbB Signaling Promotes Cell Divisions Generating Neurons from Neural Progenitor Cells in the Developing Zebrafish Brain. | Sato T et al. | β | 2015 | β |
| Neurobehavioral Differences Between Mice Receiving Distinct Neuregulin Variants as Neonates; Impact on Sensitivity to MK-801. | Kato T et al. | β | 2015 | β |
| Neuronal migration abnormalities and its possible implications for schizophrenia. | Muraki K et al. | β | 2015 | β |
| New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings. | Kotlar AV et al. | β | 2015 | β |
| Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder. | Rolstad S et al. | β | 2015 | β |
| Progressive Structural Brain Changes and NRG1 Gene Variants in First-Episode Nonaffective Psychosis. | SuΓ‘rez-Pinilla P et al. | β | 2015 | β |
| Rapid transient isoform-specific neuregulin1 transcription in motor neurons is regulated by neurotrophic factors and axon-target interactions. | Wang J et al. | β | 2015 | β |
| Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. | Samsom JN et al. | β | 2015 | β |
| Sleep and circadian rhythm disruption and recognition memory in schizophrenia. | Tam SK et al. | β | 2015 | β |
| S-SCAM, a rare copy number variation gene, induces schizophrenia-related endophenotypes in transgenic mouse model. | Zhang N et al. | β | 2015 | β |
| Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain. | Sakuma K et al. | β | 2015 | β |
| The current and potential impact of genetics and genomics on neuropsychopharmacology. | Harrison PJ | β | 2015 | β |
| The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. | Cohen SM et al. | β | 2015 | β |
| The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response. | Biernacka JM et al. | β | 2015 | β |
| Ablation of ErbB4 from excitatory neurons leads to reduced dendritic spine density in mouse prefrontal cortex. | Cooper MA et al. | β | 2014 | β |
| A blueprint for research on Shankopathies: a view from research on autism spectrum disorder. | Carbonetto S | β | 2014 | β |
| Altered expression of oligodendrocyte and neuronal marker genes predicts the clinical onset of autoimmune encephalomyelitis and indicates the effectiveness of multiple sclerosis-directed therapeutics. | Evangelidou M et al. | β | 2014 | β |
| A Neuregulin-1 schizophrenia susceptibility variant causes perihippocampal fiber tract anomalies in healthy young subjects. | Nickl-Jockschat T et al. | β | 2014 | β |
| Association of decreased prefrontal hemodynamic response during a verbal fluency task with EGR3 gene polymorphism in patients with schizophrenia and in healthy individuals. | Nishimura Y et al. | β | 2014 | β |
| Association of the 3' region of the neuregulin 1 gene with bipolar I disorder in the Chinese Han population. | Cao L et al. | β | 2014 | β |
| Behavioral phenotypes for negative symptoms in animal models of schizophrenia. | Miyamoto Y et al. | β | 2014 | β |
| Cell autonomous regulation of hippocampal circuitry via Aph1b-Ξ³-secretase/neuregulin 1 signalling. | Fazzari P et al. | β | 2014 | β |
| Classic selective sweeps revealed by massive sequencing in cattle. | Qanbari S et al. | β | 2014 | β |
| Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia. | DΓez A et al. | β | 2014 | β |
| Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. | Luo XJ et al. | β | 2014 | β |
| Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits. | Pei JC et al. | β | 2014 | β |
| Do individually ventilated cage systems generate a problem for genetic mouse model research? | Logge W et al. | β | 2014 | β |
| Dysbindin-1, a schizophrenia-related protein, interacts with HDAC3. | Soma M et al. | β | 2014 | β |
| Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity. | Agarwal A et al. | β | 2014 | β |
| Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees. | Bousman CA et al. | β | 2014 | β |
| Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development. | Paterson C et al. | β | 2014 | β |
| Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia. | Joshi D et al. | β | 2014 | β |
| Functional variants in DPYSL2 sequence increase risk of schizophrenia and suggest a link to mTOR signaling. | Liu Y et al. | β | 2014 | β |
| Genetic dissection of the psychotomimetic effects of cannabinoid exposure. | O'Tuathaigh CM et al. | β | 2014 | β |
| Genetic labeling reveals novel cellular targets of schizophrenia susceptibility gene: distribution of GABA and non-GABA ErbB4-positive cells in adult mouse brain. | Bean JC et al. | β | 2014 | β |
| Genetic mouse models of neuregulin 1: gene dosage effects, isoform-specific functions, and relevance to schizophrenia. | Law AJ | β | 2014 | β |
| Genetics and smoking. | Loukola A et al. | β | 2014 | β |
| Genetics of Psychosis in Alzheimer Disease. | DeMichele-Sweet MA et al. | β | 2014 | β |
| Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches. | Marballi KK et al. | β | 2014 | β |
| Gone to Pot - A Review of the Association between Cannabis and Psychosis. | Radhakrishnan R et al. | β | 2014 | β |
| High white matter neuron density with elevated cortical cytokine expression in schizophrenia. | Fung SJ et al. | β | 2014 | β |
| Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia. | Huang CH et al. | β | 2014 | β |
| Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses. | Hou XJ et al. | β | 2014 | β |
| Neuregulin as a heart failure therapy and mediator of reverse remodeling. | Galindo CL et al. | β | 2014 | β |
| Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. | Mei L et al. | β | 2014 | β |
| Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders. | Gross C et al. | β | 2014 | β |
| Neuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window. | Nawa H et al. | β | 2014 | β |
| New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways. | Perez SM et al. | β | 2014 | β |
| No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophrenia. | Tosato S et al. | β | 2014 | β |
| Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia. | GutiΓ©rrez-FernΓ‘ndez A et al. | β | 2014 | β |
| Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex. | Chohan TW et al. | β | 2014 | β |
| Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice. | Chohan TW et al. | β | 2014 | β |
| Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1. | O'Leary C et al. | β | 2014 | β |
| Postmortem brain: an underutilized substrate for studying severe mental illness. | McCullumsmith RE et al. | β | 2014 | β |
| Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank. | Dean B et al. | β | 2014 | β |
| Pursuit of the "truth" about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past. | DeLisi LE | β | 2014 | β |
| QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects. | Fujii K et al. | β | 2014 | β |
| Replication of linkage at chromosome 20p13 and identification of suggestive sex-differential risk loci for autism spectrum disorder. | Werling DM et al. | β | 2014 | β |
| Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice. | Luo X et al. | β | 2014 | β |
| Risk genes for schizophrenia: translational opportunities for drug discovery. | Winchester CL et al. | β | 2014 | β |
| Schizophrenia-risk variant rs6994992 in the neuregulin-1 gene on brain developmental trajectories in typically developing children. | Douet V et al. | β | 2014 | β |
| Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. | Roussos P et al. | β | 2014 | β |
| Signalling between microvascular endothelium and cardiomyocytes through neuregulin. | Parodi EM et al. | β | 2014 | β |
| Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. | Crabtree GW et al. | β | 2014 | β |
| Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness. | Kaur H et al. | β | 2014 | β |
| The chandelier cell, form and function. | Inan M et al. | β | 2014 | β |
| The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines. | Kong DC et al. | β | 2014 | β |
| The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. | Iyegbe C et al. | β | 2014 | β |
| The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation. | Grabrucker S et al. | β | 2014 | β |
| A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death. | Huertas-Vazquez A et al. | β | 2013 | β |
| A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice. | Newell KA et al. | β | 2013 | β |
| A new beginning for a broken mind: balancing neuregulin 1 reverses synaptic dysfunction. | MarΓn O et al. | β | 2013 | β |
| A new single gene deletion on 2q34: ERBB4 is associated with intellectual disability. | Kasnauskiene J et al. | β | 2013 | β |
| Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules. | Mouri A et al. | β | 2013 | β |
| An updated overview of animal models in neuropsychiatry. | Razafsha M et al. | β | 2013 | β |
| Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample. | Kukshal P et al. | β | 2013 | β |
| Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles. | Cheret C et al. | β | 2013 | β |
| Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. | Rose EJ et al. | β | 2013 | β |
| Cortical surface area correlates with STON2 gene Ser307Pro polymorphism in first-episode treatment-naΓ―ve patients with schizophrenia. | Xiang B et al. | β | 2013 | β |
| Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats. | Swerdlow NR et al. | β | 2013 | β |
| Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family. | Myles-Worsley M et al. | β | 2013 | β |
| Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. | Penzes P et al. | β | 2013 | β |
| DISC1: a key lead in studying cortical development and associated brain disorders. | Narayan S et al. | β | 2013 | β |
| Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. | Agim ZS et al. | β | 2013 | β |
| Editors' Pick: mad and genius in the same gene? | Kayser M | β | 2013 | β |
| Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. | Bousman CA et al. | β | 2013 | β |
| ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease. | Iwakura Y et al. | β | 2013 | β |
| Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. | Del Pino I et al. | β | 2013 | β |
| ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions. | Mizuno M et al. | β | 2013 | β |
| Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. | Young JW et al. | β | 2013 | β |
| Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. | Swerdlow NR et al. | β | 2013 | β |
| GABAergic interneurons shape the functional maturation of the cortex. | Le Magueresse C et al. | β | 2013 | β |
| Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment. | Wilmsdorff MV et al. | β | 2013 | β |
| Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological "minefield". | O'Tuathaigh CM et al. | β | 2013 | β |
| Hypomethylation of neuregulin in rats selectively bred for reduced sensorimotor gating. | Rhein M et al. | β | 2013 | β |
| Impact of structural aberrancy of polysialic acid and its synthetic enzyme ST8SIA2 in schizophrenia. | Sato C et al. | β | 2013 | β |
| Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. | Inan M et al. | β | 2013 | β |
| Mouse models of gene-environment interactions in schizophrenia. | Kannan G et al. | β | 2013 | β |
| Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients. | Hatzimanolis A et al. | β | 2013 | β |
| Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models. | Karl T | β | 2013 | β |
| Neuregulin-1 (NRG-1) and its susceptibility to schizophrenia: a case-control study and meta-analysis. | Loh HC et al. | β | 2013 | β |
| Neuregulin1 signaling promotes dendritic spine growth through kalirin. | Cahill ME et al. | β | 2013 | β |
| Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway. | Deng C et al. | β | 2013 | β |
| Neuregulin 1-Ξ² regulates cell adhesion molecule L1 expression in the cortex and hippocampus of mice. | Liu Y et al. | β | 2013 | β |
| Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes. | Lundgaard I et al. | β | 2013 | β |
| Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice. | Spencer JR et al. | β | 2013 | β |
| Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia. | Voineskos AN et al. | β | 2013 | β |
| Perinatal complications and schizophrenia: involvement of the immune system. | Jenkins TA | β | 2013 | β |
| Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1. | RadonjiΔ NV et al. | β | 2013 | β |
| Personalized medicine in psychiatry: problems and promises. | Ozomaro U et al. | β | 2013 | β |
| Postmortem analysis of cardiovascular deaths in schizophrenia: a 10-year review. | Sweeting J et al. | β | 2013 | β |
| Production and organization of neocortical interneurons. | Sultan KT et al. | β | 2013 | β |
| Progress in imaging the effects of psychosis susceptibility gene variants. | Redpath HL et al. | β | 2013 | β |
| Psychiatric disorder-related abnormal behavior and habenulointerpeduncular pathway defects in Wnt1-cre and Wnt1-GAL4 double transgenic mice. | Nakajima M et al. | β | 2013 | β |
| Regulation of spine formation by ErbB4 in PV-positive interneurons. | Yin DM et al. | β | 2013 | β |
| Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. | Yin DM et al. | β | 2013 | β |
| Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression. | Hu X et al. | β | 2013 | β |
| Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. | Acheson DT et al. | β | 2013 | β |
| Roles of glial cells in schizophrenia: possible targets for therapeutic approaches. | Takahashi N et al. | β | 2013 | β |
| Schizophrenia candidate gene ERBB4: covert routes of vulnerability to psychosis detected at the population level. | Stefanis NC et al. | β | 2013 | β |
| Signaling mechanisms regulating myelination in the central nervous system. | Ahrendsen JT et al. | β | 2013 | β |
| Sleep and circadian rhythm disruption in social jetlag and mental illness. | Foster RG et al. | β | 2013 | β |
| The interaction of disrupted type II neuregulin 1 and chronic adolescent stress on adult anxiety- and fear-related behaviors. | Taylor SB et al. | β | 2013 | β |
| The neuroimmunology of schizophrenia. | Smyth AM et al. | β | 2013 | β |
| Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. | Long LE et al. | β | 2013 | β |
| Type III neuregulin 1 is required for multiple forms of excitatory synaptic plasticity of mouse cortico-amygdala circuits. | Jiang L et al. | β | 2013 | β |
| What does a mouse tell us about neuregulin 1-cannabis interactions? | Karl T et al. | β | 2013 | β |
| White matter integrity as an intermediate phenotype: exploratory genome-wide association analysis in individuals at high risk of bipolar disorder. | Sprooten E et al. | β | 2013 | β |
| A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. | CarlΓ©n M et al. | β | 2012 | β |
| Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamine. | Spencer JR et al. | β | 2012 | β |
| Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. | Pratt J et al. | β | 2012 | β |
| Aggregated proteins in schizophrenia and other chronic mental diseases: DISC1opathies. | Korth C | β | 2012 | β |
| Alzheimer's therapeutics: translation of preclinical science to clinical drug development. | Savonenko AV et al. | β | 2012 | β |
| A model of neuregulin control of NMDA receptors on synaptic spines. | Bennett MR et al. | β | 2012 | β |
| Animal models of schizophrenia emphasizing construct validity. | Yanagi M et al. | β | 2012 | β |
| Annual research review: impact of advances in genetics in understanding developmental psychopathology. | Addington AM et al. | β | 2012 | β |
| Association between a Missense Polymorphism (rs3924999, Arg253Gln) of Neuregulin 1 and Schizophrenia in Korean Population. | Yang SA | β | 2012 | β |
| Association between schizophrenia and genetic variation in DCC: a case-control study. | Grant A et al. | β | 2012 | β |
| Association study of neuregulin 1 gene polymorphisms with auditory P300 in schizophrenia. | Kang C et al. | β | 2012 | β |
| Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population. | Yamada K et al. | β | 2012 | β |
| Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models. | Kvajo M et al. | β | 2012 | β |
| Bipolar disorder. | Smith DJ et al. | β | 2012 | β |
| Brain connectivity in psychiatric imaging genetics. | Tost H et al. | β | 2012 | β |
| Can genetics inform the management of cognitive deficits in schizophrenia? | Vyas NS et al. | β | 2012 | β |
| Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. | Costain G et al. | β | 2012 | β |
| Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs. | Pereira A et al. | β | 2012 | β |
| Cognition in female transmembrane domain neuregulin 1 mutant mice. | Chesworth R et al. | β | 2012 | β |
| Comprehensive analysis of NRG1 common and rare variants in Hirschsprung patients. | LuzΓ³n-Toro B et al. | β | 2012 | β |
| Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice. | Shoji H et al. | β | 2012 | β |
| Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. | Cahill ME et al. | β | 2012 | β |
| Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. | Ayalew M et al. | β | 2012 | β |
| Copy number variations in neurodevelopmental disorders. | Grayton HM et al. | β | 2012 | β |
| Discovery of common variants associated with low TSH levels and thyroid cancer risk. | Gudmundsson J et al. | β | 2012 | β |
| Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. | Long LE et al. | β | 2012 | β |
| Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update. | Keilhoff G et al. | β | 2012 | β |
| Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain. | Oyagi A et al. | β | 2012 | β |
| Evaluating the links between schizophrenia and sleep and circadian rhythm disruption. | Pritchett D et al. | β | 2012 | β |
| Family-based association study of early growth response gene 3 with child bipolar I disorder. | Gallitano AL et al. | β | 2012 | β |
| Finding a druggable target for schizophrenia. | Rico B | β | 2012 | β |
| Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. | Swerdlow NR et al. | β | 2012 | β |
| Functional diversity of actin cytoskeleton in neurons and its regulation by tropomyosin. | Schevzov G et al. | β | 2012 | β |
| Genetic architecture of declarative memory: implications for complex illnesses. | Bearden CE et al. | β | 2012 | β |
| Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population. | Bae JS et al. | β | 2012 | β |
| Genetic association of the EGR2 gene with bipolar disorder in Korea. | Kim SH et al. | β | 2012 | β |
| Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia. | Zhang R et al. | β | 2012 | β |
| Genetics of schizophrenia from a clinicial perspective. | Kukshal P et al. | β | 2012 | β |
| Genome-wide association study of treatment refractory schizophrenia in Han Chinese. | Liou YJ et al. | β | 2012 | β |
| Genome-wide copy number analysis uncovers a new HSCR gene: NRG3. | Tang CS et al. | β | 2012 | β |
| Glutamate neurocircuitry: theoretical underpinnings in schizophrenia. | Schwartz TL et al. | β | 2012 | β |
| Glutamate signaling in the pathophysiology and therapy of schizophrenia. | Lin CH et al. | β | 2012 | β |
| Human genetics of schizophrenia. | Claes S et al. | β | 2012 | β |
| Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. | Collins AL et al. | β | 2012 | β |
| Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder? | Schubert KO et al. | β | 2012 | β |
| Identification of sialyltransferase 8B as a generalized susceptibility gene for psychotic and mood disorders on chromosome 15q25-26. | McAuley EZ et al. | β | 2012 | β |
| Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. | Gupta A et al. | β | 2012 | β |
| Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. | Tosato S et al. | β | 2012 | β |
| Lack of associations of neuregulin 1 variations with schizophrenia and smooth pursuit eye movement abnormality in a Korean population. | Kim JH et al. | β | 2012 | β |
| Missense substitutions associated with behavioural disturbances in Alzheimer's disease (AD). | Proitsi P et al. | β | 2012 | β |
| Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. | Konradi C et al. | β | 2012 | β |
| Modeling psychiatric disorders at the cellular and network levels. | Brennand KJ et al. | β | 2012 | β |
| Molecular genetics of the psychosis phenotype. | DeRosse P et al. | β | 2012 | β |
| Mouse models of genetic effects on cognition: relevance to schizophrenia. | Papaleo F et al. | β | 2012 | β |
| Neonatal domoic acid treatment produces alterations to prepulse inhibition and latent inhibition in adult rats. | Marriott AL et al. | β | 2012 | β |
| Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110Ξ΄ inhibition as a potential therapeutic strategy. | Law AJ et al. | β | 2012 | β |
| Neuregulin-1/ErbB4 signaling controls the migration of oligodendrocyte precursor cells during development. | Ortega MC et al. | β | 2012 | β |
| Neuregulin-1 genotype is associated with structural differences in the normal human brain. | Barnes A et al. | β | 2012 | β |
| Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. | Andersson RH et al. | β | 2012 | β |
| Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations. | Li H et al. | β | 2012 | β |
| Neurons on the move: migration and lamination of cortical interneurons. | Faux C et al. | β | 2012 | β |
| Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene Γ environment interaction. | Desbonnet L et al. | β | 2012 | β |
| Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin. | Prox J et al. | β | 2012 | β |
| Presenilins and Ξ³-secretase: structure, function, and role in Alzheimer Disease. | De Strooper B et al. | β | 2012 | β |
| Processing of neuregulin-1 by neuropsin regulates GABAergic neuron to control neural plasticity of the mouse hippocampus. | Tamura H et al. | β | 2012 | β |
| Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. | Williams AA et al. | β | 2012 | β |
| Reliable biomarkers and predictors of schizophrenia and its treatment. | Pillai A et al. | β | 2012 | β |
| Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors. | Kaphzan H et al. | β | 2012 | β |
| Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. | Weickert CS et al. | β | 2012 | β |
| Schizophrenia genetics: putting all the pieces together. | Girard SL et al. | β | 2012 | β |
| Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. | Andreasen NC et al. | β | 2012 | β |
| Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology. | O'Tuathaigh CM et al. | β | 2012 | β |
| Synaptic dysfunction in schizophrenia. | Yin DM et al. | β | 2012 | β |
| Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia. | de Bartolomeis A et al. | β | 2012 | β |
| The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives. | Cannon DM et al. | β | 2012 | β |
| The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. | Shamir A et al. | β | 2012 | β |
| The Integration of the Glutamatergic and the White Matter Hypotheses of Schizophrenia's Etiology. | Dias AM | β | 2012 | β |
| The involvement of Type II Neuregulin-1 in rat visuospatial learning and memory. | Taylor AR et al. | β | 2012 | β |
| The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease. | Stolp H et al. | β | 2012 | β |
| The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer's Disease and Beyond. | Dislich B et al. | β | 2012 | β |
| Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders. | Goebel-Goody SM et al. | β | 2012 | β |
| The response of neuregulin 1 mutant mice to acute restraint stress. | Chesworth R et al. | β | 2012 | β |
| The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications. | Carty NC et al. | β | 2012 | β |
| Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation. | Deakin IH et al. | β | 2012 | β |
| A class representative model for Pure Parsimony Haplotyping under uncertain data. | Catanzaro D et al. | β | 2011 | β |
| Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems. | Fukuda T et al. | β | 2011 | β |
| Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. | Greenwood TA et al. | β | 2011 | β |
| Analyzing schizophrenia by DNA microarrays. | HorvΓ‘th S et al. | β | 2011 | β |
| Animal model for schizophrenia that reflects gene-environment interactions. | Nagai T et al. | β | 2011 | β |
| Animal models of schizophrenia. | Jones CA et al. | β | 2011 | β |
| A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. | Papiol S et al. | β | 2011 | β |
| A Study of the Association between SNP8NRG241930 in the 5' End of Neuroglin 1 Gene with Schizophrenia in a Group of Iranian Patients. | Mohamad Shariati SA et al. | β | 2011 | β |
| Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory. | Hillman BG et al. | β | 2011 | β |
| Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders. | Sarnyai Z et al. | β | 2011 | β |
| Biodistribution and brain permeability of the extracellular domain of neuregulin-1-Ξ²1. | RΓΆsler TW et al. | β | 2011 | β |
| Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. | Luo X et al. | β | 2011 | β |
| Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. | Brennand KJ et al. | β | 2011 | β |
| Contribution of nonprimate animal models in understanding the etiology of schizophrenia. | Lazar NL et al. | β | 2011 | β |
| Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes. | Ottis P et al. | β | 2011 | β |
| Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use. | Hunter SK et al. | β | 2011 | β |
| DISC1 in schizophrenia: genetic mouse models and human genomic imaging. | Johnstone M et al. | β | 2011 | β |
| Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice. | Nason MW et al. | β | 2011 | β |
| Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli. | Taylor SB et al. | β | 2011 | β |
| Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? | Shaikh M et al. | β | 2011 | β |
| Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit? | Karl T et al. | β | 2011 | β |
| Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophrenia. | Yamamori H et al. | β | 2011 | β |
| Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease. | Woo RS et al. | β | 2011 | β |
| Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. | Katsel P et al. | β | 2011 | β |
| Gating in schizophrenia: from genes to cognition (to real world function?). | Braff DL | β | 2011 | β |
| Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment. | Lu L et al. | β | 2011 | β |
| Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. | Rossignol E | β | 2011 | β |
| Genetic variants in the ErbB4 gene are associated with white matter integrity. | Zuliani R et al. | β | 2011 | β |
| Increased expression of receptor phosphotyrosine phosphatase-Ξ²/ΞΆ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. | Takahashi N et al. | β | 2011 | β |
| Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. | Moon E et al. | β | 2011 | β |
| Linkage and association on 8p21.2-p21.1 in schizophrenia. | Fallin MD et al. | β | 2011 | β |
| Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. | Takahashi N et al. | β | 2011 | β |
| Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology. | RΓΌnker AE et al. | β | 2011 | β |
| Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. | Ting AK et al. | β | 2011 | β |
| Neuregulin-1 signals from the periphery regulate AMPA receptor sensitivity and expression in GABAergic interneurons in developing neocortex. | Abe Y et al. | β | 2011 | β |
| Neuregulin-1Ξ² for the treatment of systolic heart failure. | Sawyer DB et al. | β | 2011 | β |
| Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. | Morar B et al. | β | 2011 | β |
| Neuregulin receptor ErbB4 functions as a transcriptional cofactor for the expression of surfactant protein B in the fetal lung. | Zscheppang K et al. | β | 2011 | β |
| Neuregulin signaling, cortical circuitry development and schizophrenia. | Rico B et al. | β | 2011 | β |
| Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. | Kurnianingsih YA et al. | β | 2011 | β |
| Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. | Balu DT et al. | β | 2011 | β |
| Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF. | Sotoyama H et al. | β | 2011 | β |
| Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia. | Hamshere ML et al. | β | 2011 | β |
| Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan. | Naz M et al. | β | 2011 | β |
| Progress in defining the biological causes of schizophrenia. | Pickard B | β | 2011 | β |
| Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia. | Geddes AE et al. | β | 2011 | β |
| Schizophrenia-related neuregulin-1 single-nucleotide polymorphisms lead to deficient smooth eye pursuit in a large sample of young men. | Smyrnis N et al. | β | 2011 | β |
| Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. | Bennett MR | β | 2011 | β |
| Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. | Pitcher GM et al. | β | 2011 | β |
| Schizophrenia: treatment targets beyond monoamine systems. | Ibrahim HM et al. | β | 2011 | β |
| Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats. | Taylor SB et al. | β | 2011 | β |
| Specific regulation of NRG1 isoform expression by neuronal activity. | Liu X et al. | β | 2011 | β |
| Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects. | Mahar I et al. | β | 2011 | β |
| The contribution of GABAergic dysfunction to neurodevelopmental disorders. | Ramamoorthi K et al. | β | 2011 | β |
| The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons. | Allison JG et al. | β | 2011 | β |
| The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. | Roussos P et al. | β | 2011 | β |
| Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model. | Martin SB et al. | β | 2011 | β |
| The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals. | KΓ©ri S et al. | β | 2011 | β |
| The role of the cerebellum in schizophrenia: from cognition to molecular pathways. | Yeganeh-Doost P et al. | β | 2011 | β |
| The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. | Boucher AA et al. | β | 2011 | β |
| Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. | Kato T et al. | β | 2011 | β |
| Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. | Kas MJ et al. | β | 2011 | β |
| TRP channels and psychiatric disorders. | Chahl LA | β | 2011 | β |
| Type III Nrg1 back signaling enhances functional TRPV1 along sensory axons contributing to basal and inflammatory thermal pain sensation. | Canetta SE et al. | β | 2011 | β |
| White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia. | Xu H et al. | β | 2011 | β |
| Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients. | Hatayama M et al. | β | 2011 | β |
| Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. | Mata I et al. | β | 2010 | β |
| Advancing a functional genomics for schizophrenia: psychopathological and cognitive phenotypes in mutants with gene disruption. | Kirby BP et al. | β | 2010 | β |
| A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. | Long LE et al. | β | 2010 | β |
| A novel analytical framework for dissecting the genetic architecture of behavioral symptoms in neuropsychiatric disorders. | Deo AJ et al. | β | 2010 | β |
| A novel method for haplotype clustering and visualization. | Teo YY et al. | β | 2010 | β |
| Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. | Walker RM et al. | β | 2010 | β |
| Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. | RΓ©thelyi JM et al. | β | 2010 | β |
| Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. | Nicodemus KK et al. | β | 2010 | β |
| Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia. | Prasad KM et al. | β | 2010 | β |
| Chemical genetics identifies small-molecule modulators of neuritogenesis involving neuregulin-1/ErbB4 signaling. | Kuai L et al. | β | 2010 | β |
| Cognition in transmembrane domain neuregulin 1 mutant mice. | Duffy L et al. | β | 2010 | β |
| Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. | BrzΓ³zka MM et al. | β | 2010 | β |
| Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. | Ibi D et al. | β | 2010 | β |
| Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. | Kao WT et al. | β | 2010 | β |
| COMT genotype and its role on hippocampal-prefrontal regions in declarative memory. | Krach S et al. | β | 2010 | β |
| Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. | Fazzari P et al. | β | 2010 | β |
| Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. | Watanabe Y et al. | β | 2010 | β |
| Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. | Seshadri S et al. | β | 2010 | β |
| Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1. | Walsh J et al. | β | 2010 | β |
| Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment. | Hayashi-Takagi A et al. | β | 2010 | β |
| Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain. | Okuda H et al. | β | 2010 | β |
| EGR3 as a potential susceptibility gene for schizophrenia in Korea. | Kim SH et al. | β | 2010 | β |
| ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. | Chen YJ et al. | β | 2010 | β |
| Executive function, neural circuitry, and genetic mechanisms in schizophrenia. | Eisenberg DP et al. | β | 2010 | β |
| Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration. | Feng Y et al. | β | 2010 | β |
| From maps to mechanisms through neuroimaging of schizophrenia. | Meyer-Lindenberg A | β | 2010 | β |
| Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. | Goto Y et al. | β | 2010 | β |
| gamma-secretases: from cell biology to therapeutic strategies. | Bergmans BA et al. | β | 2010 | β |
| Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. | Parlapani E et al. | β | 2010 | β |
| Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia. | Schmitt A et al. | β | 2010 | β |
| Genetics in schizophrenia: where are we and what next? | Tiwari AK et al. | β | 2010 | β |
| Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. | Baranzini SE et al. | β | 2010 | β |
| Heritability of DTI and MTR in nine-year-old children. | Brouwer RM et al. | β | 2010 | β |
| Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population. | So HC et al. | β | 2010 | β |
| Imaging genetics of structural brain connectivity and neural integrity markers. | Marenco S et al. | β | 2010 | β |
| Influence of neuregulin1 genotype on neural substrate of perceptual matching in children. | Mechelli A et al. | β | 2010 | β |
| Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. | Chen Y et al. | β | 2010 | β |
| Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. | Shibuya M et al. | β | 2010 | β |
| Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review. | Inta D et al. | β | 2010 | β |
| Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. | van den Buuse M | β | 2010 | β |
| Molecular and cellular characterization of Neuregulin-1 type IV isoforms. | Shamir A et al. | β | 2010 | β |
| Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain. | Tan W et al. | β | 2010 | β |
| Nature and nurture in neuropsychiatric genetics: where do we stand? | Dick DM et al. | β | 2010 | β |
| Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. | Banerjee A et al. | β | 2010 | β |
| Neuregulin-1 genotypes and eye movements in schizophrenia. | Haraldsson HM et al. | β | 2010 | β |
| Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. | Wen L et al. | β | 2010 | β |
| Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. | Hoffmann I et al. | β | 2010 | β |
| Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development. | Wilson C et al. | β | 2010 | β |
| Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801. | Okamura N et al. | β | 2010 | β |
| New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment. | Tasker RA et al. | β | 2010 | β |
| New findings in the genetics of major psychoses. | NΓΆthen MM et al. | β | 2010 | β |
| NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample. | Squassina A et al. | β | 2010 | β |
| Nrg1/ErbB signaling networks in Schwann cell development and myelination. | Newbern J et al. | β | 2010 | β |
| NRG1 gene in recurrent major depression: no association in a large-scale case-control association study. | Schosser A et al. | β | 2010 | β |
| Nrg1 reverse signaling in cortical pyramidal neurons. | Pedrique SP et al. | β | 2010 | β |
| Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression. | Fei E et al. | β | 2010 | β |
| Pharmacology of epigenetics in brain disorders. | Narayan P et al. | β | 2010 | β |
| Phenotypic characterization of transgenic mice overexpressing neuregulin-1. | Kato T et al. | β | 2010 | β |
| Positron emission tomography in schizophrenia: a new perspective. | Patel NH et al. | β | 2010 | β |
| Post-weaning social isolation increases activity in a novel environment but decreases defensive burying and subchronic MK-801 enhances the activity but not the burying effect in rats. | Simpson SM et al. | β | 2010 | β |
| Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. | Braff DL | β | 2010 | β |
| Roles of channels and receptors in the growth cone during PNS axonal regeneration. | Shim S et al. | β | 2010 | β |
| Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice. | O'Tuathaigh CM et al. | β | 2010 | β |
| Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. | Neddens J et al. | β | 2010 | β |
| Sensorimotor gating in neurotensin-1 receptor null mice. | Feifel D et al. | β | 2010 | β |
| Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. | Karam CS et al. | β | 2010 | β |
| Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis. | Lu CL et al. | β | 2010 | β |
| The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. | Baharnoori M et al. | β | 2010 | β |
| The effect of Neuregulin 1 on neural correlates of episodic memory encoding and retrieval. | Krug A et al. | β | 2010 | β |
| The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia. | Labrie V et al. | β | 2010 | β |
| The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. | Buonanno A | β | 2010 | β |
| What have the genomics ever done for the psychoses? | Gill M et al. | β | 2010 | β |
| White matter integrity, creativity, and psychopathology: disentangling constructs with diffusion tensor imaging. | Jung RE et al. | β | 2010 | β |
| WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations. | Friedrich K et al. | β | 2010 | β |
| A 5' promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression. | Nicodemus KK et al. | β | 2009 | β |
| A family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population. | Ganda C et al. | β | 2009 | β |
| Analysis of a promoter polymorphism in the SMDF neuregulin 1 isoform in Schizophrenia. | Pedrosa E et al. | β | 2009 | β |
| An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. | Prata DP et al. | β | 2009 | β |
| A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. | Mata I et al. | β | 2009 | β |
| Animal models of gene-environment interactions in schizophrenia. | Ayhan Y et al. | β | 2009 | β |
| Apoptotic engulfment pathway and schizophrenia. | Chen X et al. | β | 2009 | β |
| Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. | Maekawa M et al. | β | 2009 | β |
| A schizophrenia gene locus on chromosome 17q21 in a new set of families of Mexican and central american ancestry: evidence from the NIMH Genetics of schizophrenia in latino populations study. | Escamilla M et al. | β | 2009 | β |
| Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. | Lavedan C et al. | β | 2009 | β |
| Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia. | Shibata H et al. | β | 2009 | β |
| A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. | Gong YG et al. | β | 2009 | β |
| Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia. | Dyck BA et al. | β | 2009 | β |
| Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. | Deakin IH et al. | β | 2009 | β |
| Cannabis and psychosis/schizophrenia: human studies. | D'Souza DC et al. | β | 2009 | β |
| Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour? | Mazzoncini R et al. | β | 2009 | β |
| Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor. | Pereira A et al. | β | 2009 | β |
| [Correlations between risk gene variants for schizophrenia and brain structure anomalies]. | Nickl-Jockschat T et al. | β | 2009 | β |
| D1 receptor antagonist-induced long-term depression in the medial prefrontal cortex of rat, in vivo: an animal model of psychiatric hypofrontality. | Coppa-Hopman R et al. | β | 2009 | β |
| Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia. | Moy SS et al. | β | 2009 | β |
| Development and application of genotyping technologies. | Shi J et al. | β | 2009 | β |
| Differential distribution of neuregulin in human brain and spinal fluid. | Pankonin MS et al. | β | 2009 | β |
| DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. | Kim JY et al. | β | 2009 | β |
| Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. | Wood JD et al. | β | 2009 | β |
| Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. | Xu B et al. | β | 2009 | β |
| ErbB receptors and the development of the nervous system. | Birchmeier C | β | 2009 | β |
| Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. | Zheng Y et al. | β | 2009 | β |
| Family-based association study of Neuregulin 1 with psychotic bipolar disorder. | Goes FS et al. | β | 2009 | β |
| Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. | Chen PL et al. | β | 2009 | β |
| From age correction to genome-wide association. | Cohen-Woods S et al. | β | 2009 | β |
| Gene models of schizophrenia: DISC1 mouse models. | Jaaro-Peled H | β | 2009 | β |
| Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population. | Okochi T et al. | β | 2009 | β |
| Genetic influences on hippocampal structure and function in recombinant inbred mice. | Martin MV et al. | β | 2009 | β |
| Genetic risk for white matter abnormalities in bipolar disorder. | McIntosh AM et al. | β | 2009 | β |
| Genetics of bipolar disorder: successful start to a long journey. | Craddock N et al. | β | 2009 | β |
| Genetic variation in neuregulin1 is associated with differences in prefrontal engagement in children. | Mechelli A et al. | β | 2009 | β |
| Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals. | Kircher T et al. | β | 2009 | β |
| Genome-wide association studies in ADHD. | Franke B et al. | β | 2009 | β |
| Genome-wide comparisons of variation in linkage disequilibrium. | Teo YY et al. | β | 2009 | β |
| Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. | Holmans PA et al. | β | 2009 | β |
| Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. | Bitanihirwe BK et al. | β | 2009 | β |
| Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. | Barros CS et al. | β | 2009 | β |
| In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. | Abe Y et al. | β | 2009 | β |
| Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. | Cahill ME et al. | β | 2009 | β |
| Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder. | Boer S et al. | β | 2009 | β |
| Linkage analysis of schizophrenia controlling for population substructure. | Paunio T et al. | β | 2009 | β |
| Linkage analysis of schizophrenia in African-American families. | Wiener HW et al. | β | 2009 | β |
| Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex. | HΓΆistad M et al. | β | 2009 | β |
| Meta-analysis of 32 genome-wide linkage studies of schizophrenia. | Ng MY et al. | β | 2009 | β |
| Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia. | Wessman J et al. | β | 2009 | β |
| Modeling cognitive endophenotypes of schizophrenia in mice. | Kellendonk C et al. | β | 2009 | β |
| Mutant models for genes associated with schizophrenia. | Desbonnet L et al. | β | 2009 | β |
| Neonatal infection with neurotropic influenza A virus affects working memory and expression of type III Nrg1 in adult mice. | Asp L et al. | β | 2009 | β |
| Neuregulin 1 and age of onset in the major psychoses. | Voineskos D et al. | β | 2009 | β |
| Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. | Wang F et al. | β | 2009 | β |
| Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. | van den Buuse M et al. | β | 2009 | β |
| Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. | Kircher T et al. | β | 2009 | β |
| Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. | Fisahn A et al. | β | 2009 | β |
| Neuregulin-1 signaling in schizophrenia: 'Jack of all trades' or master of some? | O'Tuathaigh CM et al. | β | 2009 | β |
| Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. | Ehrlichman RS et al. | β | 2009 | β |
| Neuregulin beta1 enhances peak glutamate-induced intracellular calcium levels through endoplasmic reticulum calcium release in cultured hippocampal neurons. | Schapansky J et al. | β | 2009 | β |
| Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity. | Neddens J et al. | β | 2009 | β |
| Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. | Cox MM et al. | β | 2009 | β |
| Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. | Jaaro-Peled H et al. | β | 2009 | β |
| Neuropsychiatric disorders: Shared genetics of bipolar disorder and schizophrenia. | Potash JB et al. | β | 2009 | β |
| Neurotrophins induce neuregulin release through protein kinase Cdelta activation. | Esper RM et al. | β | 2009 | β |
| New findings from genetic association studies of schizophrenia. | Williams HJ et al. | β | 2009 | β |
| NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity. | Li B et al. | β | 2009 | β |
| NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. | Ramsey AJ | β | 2009 | β |
| Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice. | Tomiyama K et al. | β | 2009 | β |
| Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. | Bennett M | β | 2009 | β |
| Prepulse inhibition and genetic mouse models of schizophrenia. | Powell SB et al. | β | 2009 | β |
| Proteomic analysis reveals novel binding partners of dysbindin, a schizophrenia-related protein. | Hikita T et al. | β | 2009 | β |
| Recent diffusion tensor imaging findings in early stages of schizophrenia. | Kyriakopoulos M et al. | β | 2009 | β |
| Role of cannabis and endocannabinoids in the genesis of schizophrenia. | Fernandez-Espejo E et al. | β | 2009 | β |
| Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. | Lewis DA et al. | β | 2009 | β |
| Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. | Stober G et al. | β | 2009 | β |
| Signals of recent positive selection in a worldwide sample of human populations. | Pickrell JK et al. | β | 2009 | β |
| Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip). | Pedrosa E et al. | β | 2009 | β |
| The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. | Vassar R et al. | β | 2009 | β |
| The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. | Dutt A et al. | β | 2009 | β |
| The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1. | Freese C et al. | β | 2009 | β |
| The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants. | Sprooten E et al. | β | 2009 | β |
| Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. | Wong J et al. | β | 2009 | β |
| Update on key previously proposed candidate genes for schizophrenia. | Schwab SG et al. | β | 2009 | β |
| Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine. | Chana G et al. | β | 2009 | β |
| Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. | Liu Y et al. | β | 2009 | β |
| Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. | Morris JA | β | 2009 | β |
| Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. | Colantuoni C et al. | β | 2008 | β |
| Agrin and neuregulin, expanding roles and implications for therapeutics. | Williams S et al. | β | 2008 | β |
| Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. | Savonenko AV et al. | β | 2008 | β |
| An association study of the signal transducer and activator of transcription 6 gene with periodic psychosis. | Kawashige S et al. | β | 2008 | β |
| An interview with... Cliff Tabin. | Tabin C | β | 2008 | β |
| A protein interaction based model for schizophrenia study. | Hsu PC et al. | β | 2008 | β |
| A roadmap to disentangle the molecular etiology of schizophrenia. | Falkai P et al. | β | 2008 | β |
| Aspects of Piaget's cognitive developmental psychology and neurobiology of psychotic disorders - an integrative model. | Gebhardt S et al. | β | 2008 | β |
| Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. | KΓ€hler AK et al. | β | 2008 | β |
| Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population. | Shiota S et al. | β | 2008 | β |
| Association of 5' end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. | Winterer G et al. | β | 2008 | β |
| Association of a nonsynonymous variant of DAOA with visuospatial ability in a bipolar family sample. | Soronen P et al. | β | 2008 | β |
| Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. | Vilella E et al. | β | 2008 | β |
| Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. | Zaharieva I et al. | β | 2008 | β |
| Basic helix-loop-helix transcription factor NEUROG1 and schizophrenia: effects on illness susceptibility, MRI brain morphometry and cognitive abilities. | Ho BC et al. | β | 2008 | β |
| Beyond reliability: biomarkers and validity in psychiatry. | Pies R | β | 2008 | β |
| Biomarker discovery in psychiatric disorders. | Schwarz E et al. | β | 2008 | β |
| Calcineurin A gamma and B gene expressions in the whole blood in Japanese patients with schizophrenia. | Murata M et al. | β | 2008 | β |
| Cerebrospinal fluid: identification of diagnostic markers for schizophrenia. | Schwarz E et al. | β | 2008 | β |
| Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. | Wang XD et al. | β | 2008 | β |
| Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1. | Bray NJ et al. | β | 2008 | β |
| Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138. | Millan MJ et al. | β | 2008 | β |
| Comparative phyloinformatics of virus genes at micro and macro levels in a distributed computing environment. | Singh DT et al. | β | 2008 | β |
| Copy variations in schizophrenia and bipolar disorder. | Lachman HM | β | 2008 | β |
| Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: a correlation with BDNF expression. | Pillai A | β | 2008 | β |
| Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. | Cannon TD et al. | β | 2008 | β |
| Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. | Dejaegere T et al. | β | 2008 | β |
| Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. | Karlsgodt KH et al. | β | 2008 | β |
| Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. | Chagnon YC et al. | β | 2008 | β |
| Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1. | O'Tuathaigh CM et al. | β | 2008 | β |
| Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? | Konrad A et al. | β | 2008 | β |
| Drug discovery based on genetic and metabolic findings in schizophrenia. | Dwyer DS et al. | β | 2008 | β |
| Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. | Chong VZ et al. | β | 2008 | β |
| Emerging opportunities for antipsychotic drug discovery in the postgenomic era. | Marino MJ et al. | β | 2008 | β |
| ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. | Krivosheya D et al. | β | 2008 | β |
| Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. | Hong LE et al. | β | 2008 | β |
| Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia. | Zhang HX et al. | β | 2008 | β |
| Failure to confirm an association between Epsin 4 and schizophrenia in a Japanese population. | Richards M et al. | β | 2008 | β |
| Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. | Ikeda M et al. | β | 2008 | β |
| FBXL21 association with schizophrenia in Irish family and case-control samples. | Chen X et al. | β | 2008 | β |
| Foreword. Content versus delivery: challenges and options in the treatment of schizophrenia. | Lublin H et al. | β | 2008 | β |
| Gene expression in the etiology of schizophrenia. | Bray NJ | β | 2008 | β |
| Genes and neuroimaging: advances in psychiatric research. | Gallinat J et al. | β | 2008 | β |
| Genes and structural brain imaging in schizophrenia. | van Haren NE et al. | β | 2008 | β |
| [Genetic findings in schizophrenia]. | Mehler-Wex C et al. | β | 2008 | β |
| Genetics of bipolar disorder. | Escamilla MA et al. | β | 2008 | β |
| Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals. | Krug A et al. | β | 2008 | β |
| Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with personality traits in healthy individuals. | Krug A et al. | β | 2008 | β |
| Genomewide association for schizophrenia in the CATIE study: results of stage 1. | Sullivan PF et al. | β | 2008 | β |
| Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, Arab Israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13. | Teltsh O et al. | β | 2008 | β |
| Genomic imprinting in the development and evolution of psychotic spectrum conditions. | Crespi B | β | 2008 | β |
| Genomic structural variation and schizophrenia. | Mulle JG | β | 2008 | β |
| Identification of a chromosome 8p locus for early-onset coronary heart disease in a French Canadian population. | Engert JC et al. | β | 2008 | β |
| Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. | Ikeda M et al. | β | 2008 | β |
| Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. | Schmitt A et al. | β | 2008 | β |
| Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice. | Dean B et al. | β | 2008 | β |
| Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. | Leliveld SR et al. | β | 2008 | β |
| Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia. | Edwards TL et al. | β | 2008 | β |
| Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia. | HΓ€nninen K et al. | β | 2008 | β |
| Mechanisms of neuregulin action. | Talmage DA | β | 2008 | β |
| MEGF10 association with schizophrenia. | Chen X et al. | β | 2008 | β |
| Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. | Gallitano-Mendel A et al. | β | 2008 | β |
| Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. | Buxbaum JD et al. | β | 2008 | β |
| Neuregulin-1 and the P300 waveform--a preliminary association study using a psychosis endophenotype. | Bramon E et al. | β | 2008 | β |
| Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. | Brinkmann BG et al. | β | 2008 | β |
| Neuregulin 1 genotype and schizophrenia. | MunafΓ² MR et al. | β | 2008 | β |
| Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. | Gruber O et al. | β | 2008 | β |
| Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. | Mei L et al. | β | 2008 | β |
| Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. | Kwon OB et al. | β | 2008 | β |
| Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. | Wang YC et al. | β | 2008 | β |
| Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential. | Lawrie SM et al. | β | 2008 | β |
| Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star? | Chan RC et al. | β | 2008 | β |
| No association between the protein tyrosine phosphatase, receptor-type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population. | Ito Y et al. | β | 2008 | β |
| Presynaptic type III neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons. | Hancock ML et al. | β | 2008 | β |
| Psychiatric genetics: progress amid controversy. | Burmeister M et al. | β | 2008 | β |
| Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia. | Matsuzaki S et al. | β | 2008 | β |
| Role of glutamate in schizophrenia: integrating excitatory avenues of research. | Sodhi M et al. | β | 2008 | β |
| Schizophrenia: from developmental deviance to dopamine dysregulation. | Murray RM et al. | β | 2008 | β |
| Schizophrenia genetics: the search for a hard lead. | Sullivan PF | β | 2008 | β |
| Schizophrenia: the polygene princess and the pea. | Collier DA | β | 2008 | β |
| Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. | Nicodemus KK et al. | β | 2008 | β |
| Shared gene expression alterations in schizophrenia and bipolar disorder. | Shao L et al. | β | 2008 | β |
| Specific developmental reductions in subventricular zone ErbB1 and ErbB4 mRNA in the human brain. | Chong VZ et al. | β | 2008 | β |
| Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. | Georgieva L et al. | β | 2008 | β |
| The dice are rolling for schizophrenia genetics. | Sullivan PF | β | 2008 | β |
| The effects of a neuregulin 1 variant on white matter density and integrity. | McIntosh AM et al. | β | 2008 | β |
| The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. | Mechelli A et al. | β | 2008 | β |
| The epidermal growth factor receptor family: biology driving targeted therapeutics. | Wieduwilt MJ et al. | β | 2008 | β |
| The evolution of drug development in schizophrenia: past issues and future opportunities. | Carpenter WT et al. | β | 2008 | β |
| The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions. | Serretti A et al. | β | 2008 | β |
| The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. | Oksenberg JR et al. | β | 2008 | β |
| The hippocampus in families with schizophrenia in relation to obstetric complications. | Ebner F et al. | β | 2008 | β |
| The influence of genetics on intracranial aneurysm formation and rupture: current knowledge and its possible impact on future treatment. | Krischek B et al. | β | 2008 | β |
| The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition. | Crowley JJ et al. | β | 2008 | β |
| The role of NRG3 in mammary development. | Howard BA | β | 2008 | β |
| Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. | Chen YJ et al. | β | 2008 | β |
| Up-regulation of ADM and SEPX1 in the lymphoblastoid cells of patients in monozygotic twins discordant for schizophrenia. | Kakiuchi C et al. | β | 2008 | β |
| A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. | Guo SZ et al. | β | 2007 | β |
| Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. | Straub RE et al. | β | 2007 | β |
| Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. | Buckholtz JW et al. | β | 2007 | β |
| Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. | Mathew SV et al. | β | 2007 | β |
| Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. | Karl T et al. | β | 2007 | β |
| An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. | Vercauteren FG et al. | β | 2007 | β |
| Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. | Blackwood DH et al. | β | 2007 | β |
| Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia. | Christoforou A et al. | β | 2007 | β |
| Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. | Thomson PA et al. | β | 2007 | β |
| Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia. | Tsai SJ et al. | β | 2007 | β |
| Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. | Deng X et al. | β | 2007 | β |
| [Behavioral evaluation in animal models of schizophrenia]. | Noda Y et al. | β | 2007 | β |
| Bridging pharmacology and neurodevelopment in schizophrenia. | Kato T | β | 2007 | β |
| Can neuroscience be integrated into the DSM-V? | Hyman SE | β | 2007 | β |
| Chasing genes for mood disorders and schizophrenia in genetically isolated populations. | Venken T et al. | β | 2007 | β |
| Comorbidity implications in brain disease: neuronal substrates of symptom profiles. | Palomo T et al. | β | 2007 | β |
| Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. | Andreone N et al. | β | 2007 | β |
| Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. | Braff DL et al. | β | 2007 | β |
| Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus. | Mechawar N et al. | β | 2007 | β |
| DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. | Taya S et al. | β | 2007 | β |
| Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. | Law AJ et al. | β | 2007 | β |
| Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia. | du Bois TM et al. | β | 2007 | β |
| Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. | Nicodemus KK et al. | β | 2007 | β |
| Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. | Hennah W et al. | β | 2007 | β |
| Family-based association study of neuregulin-1 gene and psychosis in a Spanish sample. | Rosa A et al. | β | 2007 | β |
| Functional genomics and schizophrenia: endophenotypes and mutant models. | Waddington JL et al. | β | 2007 | β |
| Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. | Yamada K et al. | β | 2007 | β |
| Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. | Seshadri S et al. | β | 2007 | β |
| Genetic susceptibility for breast cancer: how many more genes to be found? | Oldenburg RA et al. | β | 2007 | β |
| Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. | Vazza G et al. | β | 2007 | β |
| Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. | Javitt DC | β | 2007 | β |
| Haplotype analysis and a novel allele-sharing method refines a chromosome 4p locus linked to bipolar affective disorder. | Le Hellard S et al. | β | 2007 | β |
| Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. | Boucher AA et al. | β | 2007 | β |
| Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. | Boucher AA et al. | β | 2007 | β |
| Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. | Stefanis NC et al. | β | 2007 | β |
| Integrating genomics and neuromarkers for the era of brain-related personalized medicine. | Gordon E | β | 2007 | β |
| Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. | Benzel I et al. | β | 2007 | β |
| Interleukin 3 and schizophrenia: the impact of sex and family history. | Chen X et al. | β | 2007 | β |
| Involvement of neuropeptide systems in schizophrenia: human studies. | CΓ‘ceda R et al. | β | 2007 | β |
| Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. | Roy K et al. | β | 2007 | β |
| Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. | Tan W et al. | β | 2007 | β |
| Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. | Addington AM et al. | β | 2007 | β |
| Neuregulin-1 enhances depolarization-induced GABA release. | Woo RS et al. | β | 2007 | β |
| Neuregulin-1 genotype moderates the association between job strain and early atherosclerosis in young men. | Hintsanen M et al. | β | 2007 | β |
| Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. | Sei Y et al. | β | 2007 | β |
| Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. | Bjarnadottir M et al. | β | 2007 | β |
| Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer. | Kanakry CG et al. | β | 2007 | β |
| Neurobiology: new order for thought disorders. | Role LW et al. | β | 2007 | β |
| Neuronal migration in the adult brain: are we there yet? | Ghashghaei HT et al. | β | 2007 | β |
| New genes associated with schizophrenia in neurite formation: a review of cell culture experiments. | Bellon A | β | 2007 | β |
| NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. | Lau CG et al. | β | 2007 | β |
| No association between the ERBB3 gene and schizophrenia in a Japanese population. | Watanabe Y et al. | β | 2007 | β |
| NRG1 and synaptic function in the CNS. | Fischbach GD | β | 2007 | β |
| Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. | Arranz MJ et al. | β | 2007 | β |
| Phenotypic and genetic complexity of psychosis. Invited commentary on ... Schizophrenia: a common disease caused by multiple rare alleles. | Craddock N et al. | β | 2007 | β |
| Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. | O'Tuathaigh CM et al. | β | 2007 | β |
| Positive association of schizophrenia to JARID2 gene. | Pedrosa E et al. | β | 2007 | β |
| Post-pubertal emergence of alterations in locomotor activity in stop null mice. | BΓ©gou M et al. | β | 2007 | β |
| Potential genetic variants in schizophrenia: a Bayesian analysis. | Hall H et al. | β | 2007 | β |
| Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism. | Wilkosz PA et al. | β | 2007 | β |
| Prioritization of positional candidate genes using multiple web-based software tools. | Thornblad TA et al. | β | 2007 | β |
| Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons. | Longart M et al. | β | 2007 | β |
| Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. | Craddock N et al. | β | 2007 | β |
| Risk factors for schizophrenia--all roads lead to dopamine. | Di Forti M et al. | β | 2007 | β |
| Schizophrenia endophenotypes as treatment targets. | Thaker GK | β | 2007 | β |
| Schizophrenia: more evidence for less glutamate. | Morrison PD et al. | β | 2007 | β |
| Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. | Fanous AH et al. | β | 2007 | β |
| Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. | O'Tuathaigh CM et al. | β | 2007 | β |
| The genetic deconstruction of psychosis. | Owen MJ et al. | β | 2007 | β |
| The genetics of bipolar affective disorder. | Farmer A et al. | β | 2007 | β |
| The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. | Li B et al. | β | 2007 | β |
| The neuronal pathology of schizophrenia: molecules and mechanisms. | Reynolds GP et al. | β | 2007 | β |
| The NRG1 exon 11 missense variant is not associated with autism in the Central Valley of Costa Rica. | McInnes LA et al. | β | 2007 | β |
| The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. | Daskalakis ZJ et al. | β | 2007 | β |
| The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. | Turunen JA et al. | β | 2007 | β |
| The role of white matter for the pathophysiology of schizophrenia. | Brambilla P et al. | β | 2007 | β |
| Translational research in the pharmaceutical industry: from theory to reality. | Sultana SR et al. | β | 2007 | β |
| Unravelling the genome: a review of molecular genetic research in schizophrenia. | Sanders J et al. | β | 2007 | β |
| Update on psychiatric genetics. | ZΓΌchner S et al. | β | 2007 | β |
| Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery. | Keller MA et al. | β | 2007 | β |
| [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts]. | Falkai P et al. | β | 2006 | β |
| Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. | Hahn CG et al. | β | 2006 | β |
| Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. | Yu Z et al. | β | 2006 | β |
| Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia. | Lachman HM et al. | β | 2006 | β |
| A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. | Hall J et al. | β | 2006 | β |
| A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. | Walss-Bass C et al. | β | 2006 | β |
| An update on the genetics of schizophrenia. | Norton N et al. | β | 2006 | β |
| A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. | Ishizuka K et al. | β | 2006 | β |
| Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population. | Walss-Bass C et al. | β | 2006 | β |
| Association of the NRG1 gene and schizophrenia: a meta-analysis. | MunafΓ² MR et al. | β | 2006 | β |
| Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis. | Li D et al. | β | 2006 | β |
| A summary statistic approach to sequence variation in noncoding regions of six schizophrenia-associated gene loci. | Winantea J et al. | β | 2006 | β |
| Axonal regulation of myelination by neuregulin 1. | Nave KA et al. | β | 2006 | β |
| Carving chaos: genetics and the classification of mood and psychotic syndromes. | Potash JB | β | 2006 | β |
| Clinical impact of recently detected susceptibility genes for schizophrenia. | Maier W et al. | β | 2006 | β |
| Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled? | Roth BL | β | 2006 | β |
| Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. | Georgieva L et al. | β | 2006 | β |
| Critical appraisal of DNA microarrays in psychiatric genomics. | Mirnics K et al. | β | 2006 | β |
| DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. | Wilson GM et al. | β | 2006 | β |
| Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. | Karl T et al. | β | 2006 | β |
| ErbB receptor signalling regulates dendrite formation in mouse cerebellar granule cells in vivo. | Rieff HI et al. | β | 2006 | β |
| Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. | Talkowski ME et al. | β | 2006 | β |
| Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. | Schwab SG et al. | β | 2006 | β |
| Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. | Severinsen JE et al. | β | 2006 | β |
| Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. | Norton N et al. | β | 2006 | β |
| Extreme population differences across Neuregulin 1 gene, with implications for association studies. | Gardner M et al. | β | 2006 | β |
| Family-based association study of Epsin 4 and Schizophrenia. | Tang RQ et al. | β | 2006 | β |
| Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. | Nicodemus KK et al. | β | 2006 | β |
| Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. | Schmidt-Kastner R et al. | β | 2006 | β |
| Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. | Craddock N et al. | β | 2006 | β |
| Genetic analysis of psychiatric disorders in humans. | van Belzen MJ et al. | β | 2006 | β |
| Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. | Gurling HM et al. | β | 2006 | β |
| Genetic association between schizophrenia and the DISC1 gene in the Scottish population. | Zhang F et al. | β | 2006 | β |
| Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. | Chen J et al. | β | 2006 | β |
| Genetics of affective (mood) disorders. | Craddock N et al. | β | 2006 | β |
| Genetics of restless legs syndrome. | Mata IF et al. | β | 2006 | β |
| Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia. | Vawter MP et al. | β | 2006 | β |
| Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. | Suarez BK et al. | β | 2006 | β |
| Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia. | Chen X et al. | β | 2006 | β |
| Human monogenic disorders - a source of novel drug targets. | Brinkman RR et al. | β | 2006 | β |
| Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. | Mah S et al. | β | 2006 | β |
| Investigating cis-acting regulatory variation using assays of relative allelic expression. | Bray NJ et al. | β | 2006 | β |
| Limited influence of olanzapine on adult forebrain neural precursors in vitro. | Councill JH et al. | β | 2006 | β |
| Linkage and association of schizophrenia with genetic variations in the locus of neuregulin 1 in Korean population. | Kim JW et al. | β | 2006 | β |
| Linkage disequilibrium analyses in the Costa Rican population suggests discrete gene loci for schizophrenia at 8p23.1 and 8q13.3. | Walss-Bass C et al. | β | 2006 | β |
| Major affective disorders and schizophrenia: a common molecular signature? | Van Den Bogaert A et al. | β | 2006 | β |
| Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. | Li D et al. | β | 2006 | β |
| Modeling madness in mice: one piece at a time. | Arguello PA et al. | β | 2006 | β |
| Molecular genetic studies of schizophrenia. | Riley B et al. | β | 2006 | β |
| Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. | Harrison PJ et al. | β | 2006 | β |
| Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. | Law AJ et al. | β | 2006 | β |
| Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. | Esper RM et al. | β | 2006 | β |
| Neurobiology of schizophrenia. | Ross CA et al. | β | 2006 | β |
| New Alzheimer's disease locus on chromosome 8. | Giedraitis V et al. | β | 2006 | β |
| Pathophysiologically based treatment interventions in schizophrenia. | Lewis DA et al. | β | 2006 | β |
| Psychosis pathways converge via D2high dopamine receptors. | Seeman P et al. | β | 2006 | β |
| Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. | Nawa H et al. | β | 2006 | β |
| Reduced Aph-1b expression causes tissue- and substrate-specific changes in gamma-secretase activity in rats with a complex phenotype. | Coolen MW et al. | β | 2006 | β |
| Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects. | Lu L et al. | β | 2006 | β |
| Schizophrenia and bipolar disorder: differences and overlaps. | Maier W et al. | β | 2006 | β |
| Schizophrenia: an integrative approach to modelling a complex disorder. | Robertson GS et al. | β | 2006 | β |
| Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. | Muller N et al. | β | 2006 | β |
| Schizophrenia--a stem cell disorder. | Eriksson PS | β | 2006 | β |
| Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model? | Scolnick EM et al. | β | 2006 | β |
| Schizophrenia genetics: uncovering positional candidate genes. | Karayiorgou M et al. | β | 2006 | β |
| Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? | Powell CM et al. | β | 2006 | β |
| Schizophrenia: signals from the other side. | Fischbach GD | β | 2006 | β |
| Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. | Carter CJ | β | 2006 | β |
| Schizophrenia susceptibility genes: emergence of positional candidates and future directions. | Gogos JA et al. | β | 2006 | β |
| Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. | O'Tuathaigh CM et al. | β | 2006 | β |
| Special issue: Molecular mechanisms of schizophrenia. | Friedman JI et al. | β | 2006 | β |
| Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population. | Fukui N et al. | β | 2006 | β |
| Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. | Steullet P et al. | β | 2006 | β |
| The involvement of ErbB4 with schizophrenia: association and expression studies. | Silberberg G et al. | β | 2006 | β |
| The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. | Hauser SL et al. | β | 2006 | β |
| The origin and specification of cortical interneurons. | Wonders CP et al. | β | 2006 | β |
| The role of neuregulin-ErbB4 interactions on the proliferation and organization of cells in the subventricular zone. | Ghashghaei HT et al. | β | 2006 | β |
| The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. | Kalkman HO | β | 2006 | β |
| Toward constructing an endophenotype strategy for bipolar disorders. | Hasler G et al. | β | 2006 | β |
| Two isoforms of GABA(A) receptor beta2 subunit with different electrophysiological properties: Differential expression and genotypical correlations in schizophrenia. | Zhao C et al. | β | 2006 | β |
| Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. | Lohoff FW et al. | β | 2006 | β |
| A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. | Hiroi N et al. | β | 2005 | β |
| Association of schizophrenia in African Americans to polymorphism in synapsin III gene. | Lachman HM et al. | β | 2005 | β |
| Bilateral lesions of the habenula induce attentional disturbances in rats. | Lecourtier L et al. | β | 2005 | β |
| Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. | Fallin MD et al. | β | 2005 | β |
| Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? | Gough SC et al. | β | 2005 | β |
| Complex trait mapping in isolated populations: Are specific statistical methods required? | Bourgain C et al. | β | 2005 | β |
| COMT genetic variation confers risk for psychotic and affective disorders: a case control study. | Funke B et al. | β | 2005 | β |
| Cortical glutamatergic markers in schizophrenia. | Scarr E et al. | β | 2005 | β |
| Developing therapeutics for schizophrenia and other psychotic disorders. | Marek G et al. | β | 2005 | β |
| Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia. | Hong LE et al. | β | 2005 | β |
| Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. | Tohmi M et al. | β | 2005 | β |
| Down-regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects. | Ftouh S et al. | β | 2005 | β |
| Endogenous neuregulin restores radial glia in a (ferret) model of cortical dysplasia. | Gierdalski M et al. | β | 2005 | β |
| Evidence and implications for multiplicative interactions among loci predisposing to human common disease. | Jones HB et al. | β | 2005 | β |
| Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. | Schumacher J et al. | β | 2005 | β |
| Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm. | Kohn Y et al. | β | 2005 | β |
| Finding schizophrenia genes. | Kirov G et al. | β | 2005 | β |
| Fine mapping of a major locus on chromosome 10 for exploratory and fear-like behavior in mice. | Zhang S et al. | β | 2005 | β |
| Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval. | Levi A et al. | β | 2005 | β |
| Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes. | Deutsch S et al. | β | 2005 | β |
| Genes contributing to risk for common forms of stroke. | Gulcher JR et al. | β | 2005 | β |
| Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. | Wong AH et al. | β | 2005 | β |
| Genetic association studies of complex traits: design and analysis issues. | Newton-Cheh C et al. | β | 2005 | β |
| Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. | Petryshen TL et al. | β | 2005 | β |
| Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? | Maier W et al. | β | 2005 | β |
| Genetics of developmental psychiatric disorders: pathways to discovery. | Joober R et al. | β | 2005 | β |
| Genetic tests of biologic systems in affective disorders. | Hattori E et al. | β | 2005 | β |
| Genome-wide association studies for common diseases and complex traits. | Hirschhorn JN et al. | β | 2005 | β |
| Genomics and new targets for multiple sclerosis. | Baranzini SE et al. | β | 2005 | β |
| Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. | Xu B et al. | β | 2005 | β |
| Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. | Liu CM et al. | β | 2005 | β |
| Looking forward in geriatric anxiety and depression: implications of basic science for the future. | Gershenfeld HK et al. | β | 2005 | β |
| Meta-analysis in psychiatric genetics. | Levinson DF | β | 2005 | β |
| Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. | Cote GM et al. | β | 2005 | β |
| Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. | Rimer M et al. | β | 2005 | β |
| Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. | Go RC et al. | β | 2005 | β |
| N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. | Millan MJ | β | 2005 | β |
| Pharmacologic implications of neurobiological models of schizophrenia. | Goff DC | β | 2005 | β |
| Principles of haplotype mapping and potential applications to attention-deficit/hyperactivity disorder. | Sklar P | β | 2005 | β |
| Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. | Gu Z et al. | β | 2005 | β |
| Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. | Fanous AH et al. | β | 2005 | β |
| Schizophrenia: an update and review. | Austin J | β | 2005 | β |
| Schizophrenia: genes at last? | Owen MJ et al. | β | 2005 | β |
| Statistical tools for linkage analysis and genetic association studies. | Forabosco P et al. | β | 2005 | β |
| Support for involvement of neuregulin 1 in schizophrenia pathophysiology. | Petryshen TL et al. | β | 2005 | β |
| Techniques for the identification of genes involved in psychiatric disorders. | Blair IP et al. | β | 2005 | β |
| The genetics of schizophrenia and bipolar disorder: dissecting psychosis. | Craddock N et al. | β | 2005 | β |
| The neurodevelopmental model of schizophrenia: update 2005. | Rapoport JL et al. | β | 2005 | β |
| Workshop Abstracts. | Gurwitz D | β | 2005 | β |